$3.39+0.11 (+3.35%)
Community Health Systems, Inc.
Community Health Systems, Inc. in the Healthcare sector is trading at $3.39 with a market capitalization of $442M. Wall Street consensus targets $3.31 (7 analysts), implying a -2.2% move over the next 12 months. The stock is currently 23% below its 52-week high of $4.43, remaining 6.9% above its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.96Bβ | $3.11Bβ | $3.09Bβ | $3.13Bβ | $3.16B |
| Gross Profit | $2.52Bβ | $2.66Bβ | $2.63Bβ | $2.66Bβ | $2.67B |
| Operating Income | $191.00Mβ | $286.00Mβ | $264.00Mβ | $273.00Mβ | $260.00M |
| Net Income | -$58.00Mβ | $110.00Mβ | $130.00Mβ | $282.00Mβ | -$13.00M |
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnosti...
Hospital stocks are adapting to shifting care trends, with Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems in focus.
The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.
With shares lagging and revenue growth slowing, the market seems to be missing the powerful engine driving HCA's per-share earnings higher.
CYH has cut billions in debt, but can improving operations keep the turnaround alive and ease leverage concerns?
Community Health Systems is back in focus after multiple firms trimmed their price targets by $0.50, signalling a more cautious stance without a full reset of the story. These revisions track closely with analyst commentary that frames the proposed Centers for Medicare and Medicaid Services rule as neutral to slightly negative, pointing to incremental pressure rather than a major shock. As you read on, you will see how these price target moves fit into the evolving narrative around policy...